Research Frontiers (REFR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,121 | 1,336 | 910 | 540 | 1,263 |
| Cost of Goods | 2,645 | 2,207 | 2,360 | 2,556 | 2,522 |
| Gross Profit | -1,523 | -872 | -1,450 | -2,016 | -1,259 |
| Operating Expenses | 1,253 | 777 | 943 | 1,165 | 1,102 |
| Operating Income | -2,132 | -1,442 | -2,033 | -2,625 | -1,839 |
| Other Income | 87 | 131 | 125 | -44 | -8 |
| Pre-tax Income | -2,046 | -1,311 | -1,908 | -2,669 | -1,846 |
| Net Income Continuous | -2,046 | -1,311 | -1,908 | -2,669 | -1,846 |
| Net Income | $-2,046 | $-1,311 | $-1,908 | $-2,669 | $-1,846 |
| EPS Basic Total Ops | -0.06 | -0.04 | -0.06 | -0.08 | -0.06 |
| EPS Basic Continuous Ops | -0.06 | -0.04 | -0.06 | -0.08 | -0.06 |
| EPS Diluted Total Ops | -0.06 | -0.04 | -0.06 | -0.08 | -0.06 |
| EPS Diluted Continuous Ops | -0.06 | -0.04 | -0.06 | -0.08 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.04 | -0.06 | -0.08 | -0.06 |
| EBITDA(a) | $-1,946 | $-1,178 | $-1,861 | $-2,450 | $-1,662 |